A critical remaining question is whether the changes observed in IGF-II/H19 are a consequence of the genetic/epigenetic alterations that occur in neoplastic cells or whether epigenetic alteration in IGF-II/H19 predisposes tissues to the development of cancer. Here, H19 is linked to cancer.